HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,022,299 | +307.3% | 57,468 | +277.9% | 0.05% | +278.6% |
Q1 2023 | $496,574 | -72.9% | 15,209 | -54.3% | 0.01% | -73.1% |
Q4 2022 | $1,832,681 | +349.2% | 33,261 | +261.0% | 0.05% | +271.4% |
Q3 2022 | $408,000 | -46.2% | 9,214 | -40.8% | 0.01% | -58.8% |
Q2 2022 | $759,000 | +3.8% | 15,558 | +3.5% | 0.03% | 0.0% |
Q1 2022 | $731,000 | +16.8% | 15,028 | +2.4% | 0.03% | -12.8% |
Q4 2021 | $626,000 | -20.2% | 14,674 | -28.3% | 0.04% | -37.1% |
Q3 2021 | $784,000 | +148.1% | 20,460 | +82.9% | 0.06% | +129.6% |
Q2 2021 | $316,000 | – | 11,188 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |